Pharmaceutical Technology
March 02, 2015
Regulatory Watch
39
3
Scientists and industry experts seek effective preventive therapies to combat global disease.
March 02, 2015
Regulatory Watch
39
3
Proposals to make the decentralized procedure more efficient were discussed at the January 2015 EGA conference.
March 02, 2015
Product Spotlight
39
3
Kason’s K-Series screen replacement program for round vibratory screeners decreases downtime and cost and offers screens designed for any make or model of screener.
March 02, 2015
Product Spotlight
39
3
GEA Niro Soavi’s PandaPLUS 2000 is a tabletop laboratory homogenizer that is designed for the treatment of nanoparticles, nanodispersions, nanoemulsions, and cell disruption.
March 02, 2015
Product Spotlight
39
3
PolyScience’s recirculating chillers and refrigerated circulators control temperature with stabilities as precise as ±0.005 °C for analytical instrumentation.
March 02, 2015
Product Spotlight
39
3
Ross’ SysCon PLC-based Control Systems are designed for sequential control of automated processes including mixing, pumping, chemical dosing, water treatment, fractionation, and heat exchange.
March 02, 2015
Industry Leaders
39
3
Richard Grant, Global VP of Cell Therapy at Invetech discusses the advantages and challenges of developing and manufacturing personalized immunotherapies.
March 02, 2015
Ask the Expert
39
3
Siegfried Schmitt, Principal Consultant, PAREXEL International, discusses good engineering practices.
March 02, 2015
Global Market Report
39
3
The fast growth of the global biopharmaceutical market has prompted global pharmaceutical and biotechnology companies to increase their R&D investment in biologics.
March 02, 2015
Cover Story
39
3
While the optimization of a lyophilization cycle for a biologic relies on a well-characterized formulation, viscosity and aggregation after product reconstitution must also be carefully managed.
March 02, 2015
API Synthesis and Manufacturing
39
3
Protecting workers, patients, and the environment requires advanced technologies.
March 02, 2015
Insider Solutions
39
3
A new technical report guides bio/pharma companies in establishing a risk-based approach for prevention and management of drug shortages.
March 02, 2015
From The Editor
39
3
Sessions address cell therapies, tableting, continuous processes, serialization, and more.
March 02, 2015
Special Report
39
3
Assessing risk factors is key to implementing the new ICH Q3D guidelines for elemental impurities.
March 02, 2015
Formulation
39
3
While the skin offers an alternative route of administration for local and systemic drug delivery, developing semi-solid dosage forms can be a challenge.
March 02, 2015
GMP Facility Design
39
3
Cleanability is crucial when choosing components for GMP manufacturing areas.
March 02, 2015
Peer-Reviewed Research
39
3
The pharmaceutical manufacturing platforms of fluid-bed granulation and milling are widely used to modify particle size. However, the adoption of process analytical technology to monitor and control these processes is difficult because of their dynamic nature. This study examines the efficacy of a particle characterizing technology to capture particle images under dynamic conditions and to calculate particle size distribution data both in-line and at-line during fluid-bed granulation and milling.
March 02, 2015
Troubleshooting
39
3
Several chromatographic resins are available for downstream purification.
March 02, 2015
Outsourcing Outlook
39
3
Is there enough talent to go around?
March 02, 2015
Inside USP
39
3
A General Chapter on mAbs will be published in USP-NF as biologics increase their role in healthcare.
March 02, 2015
Issue PDF
39
3
Click the title above to open the Pharmaceutical Technology March 2015 issue in an interactive PDF format.